424 filings
8-K
SLNO
Soleno Therapeutics Inc
20 Jun 24
Entry into a Material Definitive Agreement
4:17pm
8-K
SLNO
Soleno Therapeutics Inc
6 Jun 24
Submission of Matters to a Vote of Security Holders
4:29pm
8-K
SLNO
Soleno Therapeutics Inc
9 May 24
Soleno Therapeutics Provides Corporate Update and Reports First Quarter 2024 Financial Results
7:36pm
10-Q
2024 Q1
SLNO
Soleno Therapeutics Inc
Quarterly report
9 May 24
4:31pm
8-K
SLNO
Soleno Therapeutics Inc
7 May 24
Soleno Therapeutics Announces Pricing of Approximately $138 Million Public Offering of Common Stock
5:28pm
424B5
9eosy9e4
6 May 24
Prospectus supplement for primary offering
4:58pm
424B5
l8nv6gd7sq63mb38kt
2 May 24
Prospectus supplement for primary offering
4:04pm
8-K
lt4su
29 Apr 24
First Ever Breakthrough Designation for a Drug Being Developed for PWS
4:08pm
ARS
khzp2rs7bg0
22 Apr 24
Annual report to shareholders
5:06pm
8-K
maazr t4hu
22 Apr 24
Departure of Directors or Certain Officers
4:15pm
8-K
stf4dh
7 Mar 24
Soleno Therapeutics Provides Corporate Update and Reports Fourth Quarter and Full-Year 2023 Financial Results
6:06am
S-8
42aq8vpjzp01x
31 Jan 24
Registration of securities for employees
4:19pm
8-K
h0rvv
30 Jan 24
Departure of Directors or Certain Officers
4:57pm
S-8
cfgm1z kmn
17 Jan 24
Registration of securities for employees
4:06pm
8-K
vktif4omk
5 Jan 24
Departure of Directors or Certain Officers
4:16pm
S-3ASR
5yw1f ns09u8i
2 Jan 24
Automatic shelf registration
4:06pm
EFFECT
xlsfgli
1 Nov 23
Notice of effectiveness
12:15am